Grifols S.A. ADR Stock
Grifols S.A. ADR Stock
The Grifols S.A. ADR stock is trending slightly upwards today, with an increase of €0.050 (0.660%) compared to yesterday's price.
Pros and Cons of Grifols S.A. ADR in the next few years
Pros
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Cons
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Grifols S.A. ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Grifols S.A. ADR | 0.660% | -3.797% | 0.662% | 9.353% | 0.000% | -11.628% | -42.311% |
| Eledon Pharmaceuticals Inc. | 0.000% | 16.092% | 9.189% | -47.938% | 57.813% | -15.833% | -84.925% |
| Beximco Pharmaceuticals Ltd. GDR | 0.000% | 0.000% | 0.000% | 18.119% | 14.955% | 3.831% | -46.907% |
| SELLAS Life Sciences Group Inc | 4.160% | 19.751% | 6.501% | 259.813% | 35.802% | 135.402% | -43.861% |
Comments
Grifols, S.A. (NASDAQ: GRFS) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for GRFS provided by MarketBeat
Grifols, S.A. (NASDAQ: GRFS) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for GRFS provided by MarketBeat
Grifols, S.A. (NASDAQ: GRFS) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
Show more
Ratings data for GRFS provided by MarketBeat